Lorusso, Domenica
 Distribuzione geografica
Continente #
AS - Asia 475
NA - Nord America 114
EU - Europa 30
AF - Africa 1
SA - Sud America 1
Totale 621
Nazione #
SG - Singapore 382
US - Stati Uniti d'America 113
CN - Cina 91
CZ - Repubblica Ceca 12
DE - Germania 7
IT - Italia 6
FI - Finlandia 3
ES - Italia 2
HK - Hong Kong 2
BR - Brasile 1
CA - Canada 1
ZA - Sudafrica 1
Totale 621
Città #
Singapore 260
Shanghai 91
Boardman 26
Santa Clara 12
Brno 7
Munich 6
Olomouc 5
Turin 4
Helsinki 3
Hong Kong 2
Naples 2
Pamplona 2
Engelhard 1
Hamm 1
Kensington 1
Miami 1
New York 1
Pretoria 1
São Paulo 1
Totale 427
Nome #
Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance 8
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor 8
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience. 8
Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case 8
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses 7
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy 7
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses 7
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 6
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib 6
Management of stage III and IVa uterine cancer 6
Celecoxib plus cartioplatin in heavily pre-treated patients with recurrent ovarian carcinoma: Preliminary results of a Phase II study 5
Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach 5
Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma A Retrospective Cohort Study 5
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 5
28. Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin-Broto J, Brahmi M, Collini P, Lorusso D, Raspagliesi F, Pantaleo MA, Vincenzi B, Fumagalli E, Gronchi A, Casali PG, Sanfilippo R 5
Advances in laparoscopic surgery for cervical cancer 5
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer 5
Tumori dell'ovaio 5
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] 5
3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy 5
Chemotherapy in endometrial cancer. 5
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies 5
A critical assessment on the role of sentinel node mapping in endometrial cancer 5
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer 5
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study 5
Extraperitoneal Robotic-Assisted Para-Aortic Lymphadenectomy in Gynecologic Cancer Staging: Current Evidence 5
Newly diagnosed ovarian cancer: Which first-line treatment? 5
Do you agree with populations that have been defined as 'noncandidates' to receiving platinum? 4
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives 4
Invasive Paget Disease of the Vulva. 4
Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis 4
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 4
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival 4
When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer 4
Tailoring adjuvant treatment in patients with uterine cancer 4
Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study 4
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) 4
Sentinel Node Mapping in Endometrial Cancer By Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging: A Preliminary Experience 4
Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures 4
Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives 4
Il carcinoma dell'ovaio 4
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer 4
Tumori dell'apparato genitale femminile 4
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features 4
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study 4
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery 4
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 4
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer 4
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 4
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial 4
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study 4
Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 4
Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis 4
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment 4
Prospective validation of a predictive score for complete tumor resection in recurrent ovarian cancer (ROC): an intergroup study of AGO kommission OVAR, AGO-OVAR, AGO Austria, MITO and NOGGO 4
Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green 4
Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases 4
Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement 4
"Tumori della vulva e della vagina" 4
The role of niraparib in the treatment of ovarian cancer: actuality and perspectives 4
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives 4
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety 4
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study 4
Sonographic imaging of urinoma 4
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 4
Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer 4
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO 4
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer 4
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 4
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach? 4
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer 4
Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery 4
Sentinel lymph node detection in endometrial cancer: make injection site the difference? 4
Potential impact of introducing a nonavalent HPV vaccination 4
Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study 4
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 4
Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity 4
Adoptive immunotherapy with cytokine-induced killer cells generated with a new GMP-grade protocol 4
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 4
Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery: our experience and analysis of the literature 4
Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia. 4
Uterine serous carcinoma 4
Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery 4
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial 3
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 3
Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study 3
Findings Linking Mismatch Repair Mutation With Age at Endometrial and Ovarian Cancer Onset in Lynch Syndrome 3
Emerging drugs for ovarian cancer 3
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study 3
Pegylated liposomal doxorubicin in the management of ovarian cancer 3
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience 3
Rucaparib: a new treatment option for ovarian cancer 3
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 3
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? 3
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV) 3
Treatment of recurrent ovarian cancer with pegylated liposomal doxorubicin: a reappraisal and critical analysis 3
Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors 3
Stereotactic radiotherapy in recurrent gynecological cancer: A case series 3
Fertility sparing surgery in early stage epithelial ovarian cancer 3
Totale 433
Categoria #
all - tutte 12.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.173

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024854 0 0 0 0 0 0 0 0 271 18 179 386
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 905